Serum Trefoil Factor-3 Predicts Survival in Peripheral Artery Disease
Open Access
- 5 February 2024
- journal article
- research article
- Published by SAGE Publications in Angiology
- Vol. 76 (5) , 409-415
Abstract
Trefoil factor 3 (TFF3) has been studied in processes leading to atherosclerosis. Data are scarce in manifest disease and missing in peripheral artery disease (PAD). This study aims to elucidate TFF3 with disease stages, degrees of atherosclerosis, and outcomes. TFF3 was measured in serum in 364 PAD patients without critical limb ischemia and mild to moderate chronic kidney disease (CKD). Mortality data were retrieved from the Austrian central death registry (median observation 9.6 years). Survival analyses were performed using Cox regression and the Kaplan–Meier method. A negative association between ankle-brachial index and TFF3 ( P < .001) was observed, while levels were similar in asymptomatic and symptomatic PAD. TFF3 increased with history of cardiovascular and cerebrovascular disease ( P < .001). TTF3 was associated with the estimated glomerular filtration rate (R = −0.617, P < .001) and urinary albumin-creatinine ratio (R = 0.229, P < .001). One SD increase in TFF3 showed a worsening in all-cause mortality (hazard ratio 1.68, CI 1.37–2.05) which persisted after multiple adjustment for cardiovascular risk, inflammatory, and angiogenetic markers (hazard ratio 1.35, CI 1.01–1.81). This study is the first to link TFF3 with both disease markers and outcomes in PAD. TFF3 demonstrated associations with renal function, PAD severity measured by ankle-brachial index, and additional atherosclerotic burden in PAD.Keywords
Funding Information
- Medizinische Universität Wien
This publication has 26 references indexed in Scilit:
- Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2PLOS ONE, 2015
- Tff3 is Expressed in Neurons and Microglial CellsCellular Physiology and Biochemistry, 2014
- Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice GuidelineAnnals of Internal Medicine, 2013
- Trefoil Factor 3 Predicts Incident Chronic Kidney Disease: A Case-Control Study Nested within the Atherosclerosis Risk in Communities (ARIC) StudyAmerican Journal of Nephrology, 2011
- The trefoil factor family – small peptides with multiple functionalitiesCellular and Molecular Life Sciences, 2008
- Regulation and Function of Trefoil Factor Family 3 Expression in the Biliary TreeThe American Journal of Pathology, 2004
- Trefoil peptides as proangiogenic factors in vivo and in vitro: implication of cyclooxygenase‐2 and EGF receptor signalingThe FASEB Journal, 2003
- Intestinal trefoil factor binds to intestinal epithelial cells and induces nitric oxide production: priming and enhancing effects of mucinBiochemical Journal, 1999
- Characterization of Human and Rat Intestinal Trefoil Factor Produced in YeastBiochemistry, 1995
- hP1.B, a human P-domain peptide homologous with rat intestinal trefoil factor, is expressed also in the ulcer-associated cell lineage and the uterus.Proceedings of the National Academy of Sciences, 1993